I-Mab (IMAB)
USD 0.95
(8.63%)
USD 0.95
(8.63%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.61 Billion CNY | -35.86% |
| 2022 | 4.07 Billion CNY | -27.64% |
| 2021 | 5.62 Billion CNY | -11.12% |
| 2020 | 6.33 Billion CNY | 264.52% |
| 2019 | 1.73 Billion CNY | -26.87% |
| 2018 | 2.37 Billion CNY | 131.72% |
| 2017 | 1.02 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.84 Billion CNY | 0.0% |
| 2023 FY | 2.61 Billion CNY | -35.86% |
| 2023 Q3 | 2.61 Billion CNY | -25.59% |
| 2023 Q2 | 3.51 Billion CNY | 0.0% |
| 2023 Q1 | 3.51 Billion CNY | -13.8% |
| 2023 Q4 | 2.61 Billion CNY | 0.0% |
| 2022 FY | 4.07 Billion CNY | -27.64% |
| 2022 Q3 | 4.07 Billion CNY | -18.39% |
| 2022 Q1 | 4.99 Billion CNY | -11.33% |
| 2022 Q2 | 4.99 Billion CNY | 0.0% |
| 2022 Q4 | 4.07 Billion CNY | 0.0% |
| 2021 Q1 | 6.14 Billion CNY | -2.93% |
| 2021 FY | 5.62 Billion CNY | -11.12% |
| 2021 Q4 | 5.62 Billion CNY | 0.5% |
| 2021 Q2 | 6.14 Billion CNY | 0.0% |
| 2021 Q3 | 5.6 Billion CNY | -8.89% |
| 2020 Q4 | 6.33 Billion CNY | 47.36% |
| 2020 Q3 | 4.29 Billion CNY | 109.79% |
| 2020 Q2 | 2.04 Billion CNY | 0.0% |
| 2020 Q1 | 2.04 Billion CNY | 17.91% |
| 2020 FY | 6.33 Billion CNY | 264.52% |
| 2019 Q3 | 1.83 Billion CNY | -5.92% |
| 2019 Q2 | 1.95 Billion CNY | 0.0% |
| 2019 Q1 | 1.95 Billion CNY | -17.7% |
| 2019 Q4 | 1.73 Billion CNY | -5.55% |
| 2019 FY | 1.73 Billion CNY | -26.87% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 2.37 Billion CNY | 131.72% |
| 2018 Q4 | 2.37 Billion CNY | 0.0% |
| 2017 FY | 1.02 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -82172.261% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -230695.056% |
| XOMA Corporation | 234.3 Million USD | -1015.218% |
| Mesoblast Limited | 669.15 Million USD | -290.489% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -666.72% |
| Aptorum Group Limited | 20.64 Million USD | -12559.668% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -128411.967% |
| HilleVax, Inc. | 344.43 Million USD | -658.626% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -361.377% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -9142.115% |
| Precision BioSciences, Inc. | 159.78 Million USD | -1535.343% |
| Dyadic International, Inc. | 8.21 Million USD | -31690.874% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -15008.222% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -302.418% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -8132.41% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -2574.891% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -635.666% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -295.225% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -1432.397% |
| IGM Biosciences, Inc. | 423.41 Million USD | -517.123% |
| Opthea Limited | 188.79 Million USD | -1284.051% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -3373.489% |
| Abeona Therapeutics Inc. | 64 Million USD | -3982.633% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -1591.712% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -213.657% |
| NextCure, Inc. | 129.41 Million USD | -1919.014% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -17912.205% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -1714.223% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -3371.551% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -508.513% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -1453.728% |
| Senti Biosciences, Inc. | 119.48 Million USD | -2086.876% |
| Apollomics, Inc. | 55.38 Million USD | -4617.654% |
| PureTech Health plc | 693.97 Million USD | -276.523% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -7014.18% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -1118.132% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -353.83% |
| ChromaDex Corporation | 54.96 Million USD | -4653.961% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -35474.002% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -981.065% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -1480.551% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -32649.553% |
| Gritstone bio, Inc. | 177.76 Million USD | -1369.867% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -27038.278% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -416.175% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -3445.314% |
| Fortress Biotech, Inc. | 167.52 Million USD | -1459.738% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -48486.222% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -2614.714% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -248.382% |
| Celcuity Inc. | 191.21 Million USD | -1266.476% |
| ContextLogic Inc. | 423 Million USD | -517.723% |
| GH Research PLC | 226.3 Million USD | -1054.647% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -1519.571% |
| Cassava Sciences, Inc. | 151.66 Million USD | -1622.877% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -29575.945% |
| ImmuCell Corporation | 43.8 Million USD | -5864.575% |
| Amarin Corporation plc | 831.68 Million USD | -214.178% |
| TG Therapeutics, Inc. | 329.58 Million USD | -692.8% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -1674.414% |
| Acelyrin, Inc. | 742.69 Million USD | -251.825% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -44396.779% |
| Seer, Inc. | 436.26 Million USD | -498.935% |
| Novavax, Inc. | 1.85 Billion USD | -40.835% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -531.392% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 77.066% |
| AnaptysBio, Inc. | 452.38 Million USD | -477.593% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -10418.344% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -936.267% |
| AbCellera Biologics Inc. | 1.48 Billion USD | -75.592% |
| CorMedix Inc. | 82.05 Million USD | -3084.217% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -756.57% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -15156.071% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 92.101% |
| Aptose Biosciences Inc. | 12.92 Million USD | -20120.221% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -11715.743% |
| Soligenix, Inc. | 9.79 Million USD | -26570.206% |
| Century Therapeutics, Inc. | 360.69 Million USD | -624.434% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -241.318% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -50443.871% |
| Kura Oncology, Inc. | 448.93 Million USD | -482.037% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -1407.519% |
| Ardelyx, Inc. | 297.57 Million USD | -778.075% |
| Ainos, Inc. | 31.84 Million USD | -8106.09% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -860.124% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -2255.906% |
| Prothena Corporation plc | 696.38 Million USD | -275.22% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -1173.68% |
| Autolus Therapeutics plc | 375.38 Million USD | -596.084% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -938.392% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -824.564% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -5218.259% |
| Celularity Inc. | 143.88 Million USD | -1715.96% |
| Rallybio Corporation | 115.62 Million USD | -2159.961% |
| GRI Bio, Inc. | 2.95 Million USD | -88295.365% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -24538.485% |
| Omeros Corporation | 378.26 Million USD | -590.77% |
| INmune Bio, Inc. | 57 Million USD | -4484.072% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -1074.336% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -3012.852% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -9904.906% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -37861.543% |
| Humacyte, Inc. | 128.22 Million USD | -1937.83% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -1478.794% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -315.018% |
| Immunocore Holdings plc | 597 Million USD | -337.682% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -8259.087% |
| Verastem, Inc. | 149.71 Million USD | -1645.259% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -410.192% |
| Histogen Inc. | 19.07 Million USD | -13599.822% |
| Surrozen, Inc. | 46.08 Million USD | -5570.501% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -149.032% |
| Organovo Holdings, Inc. | 6.34 Million USD | -41055.568% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -60545.102% |
| IO Biotech, Inc. | 150.71 Million USD | -1633.679% |
| MEI Pharma, Inc. | 41.37 Million USD | -6215.328% |
| GT Biopharma, Inc. | 14.1 Million USD | -18419.86% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -619.887% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -14340.752% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -930.147% |
| Summit Therapeutics Inc. | 202.94 Million USD | -1187.499% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -31522.498% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -1428.873% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -20618.562% |
| Turnstone Biologics Corp. | 112.81 Million USD | -2216.152% |
| Pulmatrix, Inc. | 33.95 Million USD | -7594.702% |
| Synaptogenix, Inc. | 31.11 Million USD | -8298.133% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -21345.888% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -376.765% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -1755.036% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -100.847% |
| Cytokinetics, Incorporated | 824.31 Million USD | -216.986% |
| Exelixis, Inc. | 2.94 Billion USD | 11.195% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -616.787% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -231.288% |
| Evogene Ltd. | 51.1 Million USD | -5013.338% |
| Replimune Group, Inc. | 487.72 Million USD | -435.749% |
| PDS Biotechnology Corporation | 59.39 Million USD | -4299.669% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -27346.331% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -2639.533% |
| ESSA Pharma Inc. | 149.12 Million USD | -1652.233% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -14528.415% |
| BioLineRx Ltd. | 63.92 Million USD | -3987.551% |
| Avid Bioservices, Inc. | 336.55 Million USD | -676.382% |
| Insmed Incorporated | 1.32 Billion USD | -96.488% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -2013.145% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -364.918% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -2601.607% |
| MediWound Ltd. | 66.45 Million USD | -3831.698% |
| MiMedx Group, Inc. | 239.04 Million USD | -993.077% |
| OmniAb, Inc. | 401.98 Million USD | -550.016% |
| Alector, Inc. | 621.82 Million USD | -320.208% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -628.658% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | -37.295% |
| Mereo BioPharma Group plc | 66.49 Million USD | -3829.333% |
| Zai Lab Limited | 1.03 Billion USD | -152.145% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -446.127% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -326.342% |
| Aura Biosciences, Inc. | 255.07 Million USD | -924.392% |
| Immunic, Inc. | 54.29 Million USD | -4712.183% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -1482.83% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -881.492% |
| Veracyte, Inc. | 1.13 Billion USD | -129.647% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -22001.118% |
| FibroGen, Inc. | 423.52 Million USD | -516.951% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -74279.932% |
| Allakos Inc. | 243.61 Million USD | -972.603% |
| scPharmaceuticals Inc. | 94.47 Million USD | -2665.659% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -913.981% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -320.418% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -55065.398% |
| NLS Pharmaceutics AG | 1.84 Million USD | -141398.375% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -48025.566% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -404.966% |
| Precigen, Inc. | 151.04 Million USD | -1629.949% |
| Fortrea Holdings Inc. | 4.35 Billion USD | 40.031% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -1009.993% |
| Incyte Corporation | 6.78 Billion USD | 61.473% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -413613.845% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -1976.354% |
| XBiotech Inc. | 227.24 Million USD | -1049.856% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -1597.801% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -2639.533% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -13707.926% |
| CRISPR Therapeutics AG | 2.22 Billion USD | -17.196% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -350.301% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -2265.34% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -1732.375% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -813.893% |
| Agenus Inc. | 313.91 Million USD | -732.386% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -18956.241% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -1943.472% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -584.025% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -75.248% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -616.191% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -84626.941% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -405.449% |
| UroGen Pharma Ltd. | 178.31 Million USD | -1365.399% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -13941.166% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -455.081% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -24285.634% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -4677.429% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -11696.088% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -1044.322% |
| Chimerix, Inc. | 212.77 Million USD | -1128.048% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -2332.115% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -7989.431% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -33469.423% |
| Pluri Inc. | 39.52 Million USD | -6510.588% |
| Cue Biopharma, Inc. | 61.53 Million USD | -4146.655% |
| MeiraGTx Holdings plc | 458.16 Million USD | -470.308% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -11436.19% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -30571.327% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -3712.88% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -14380.316% |
| CalciMedica, Inc. | 12.18 Million USD | -21344.128% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -740.088% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -362.227% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -9525.606% |
| NLS Pharmaceutics AG | 1.84 Million USD | -141398.375% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -1907.056% |
| Nutriband Inc. | 7.51 Million USD | -34660.057% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -3209.48% |
| Vor Biopharma Inc. | 209.82 Million USD | -1145.29% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 63.822% |
| ProKidney Corp. | 420.55 Million USD | -521.318% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -4665.318% |
| Daré Bioscience, Inc. | 21.28 Million USD | -12177.702% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -378.233% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -32214.704% |
| Bicycle Therapeutics plc | 595.34 Million USD | -338.9% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -549.076% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -9165.84% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | -25.107% |
| Atai Life Sciences N.V. | 293.47 Million USD | -790.345% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -1501.775% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -1950.705% |
| MediciNova, Inc. | 66.26 Million USD | -3842.912% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -2871.036% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -58455.654% |
| GeoVax Labs, Inc. | 9.28 Million USD | -28047.208% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -629.979% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -344.204% |
| Biomea Fusion, Inc. | 199.92 Million USD | -1206.961% |
| RenovoRx, Inc. | 1.46 Million USD | -178137.858% |
| Erasca, Inc. | 395.29 Million USD | -561.014% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -438.649% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -35620.67% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -668.766% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -396.458% |
| bluebird bio, Inc. | 619.16 Million USD | -322.017% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -840.955% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -6655.344% |
| Imunon, Inc. | 21.91 Million USD | -11821.52% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 61.808% |
| BioAtla, Inc. | 119.65 Million USD | -2083.696% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -306.474% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -2623.685% |
| DBV Technologies S.A. | 182.98 Million USD | -1327.96% |
| Fortress Biotech, Inc. | 167.52 Million USD | -1459.738% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -315.71% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -1081.082% |
| aTyr Pharma, Inc. | 122.06 Million USD | -2040.601% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -432.798% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -17138.706% |
| Galecto, Inc. | 38.22 Million USD | -6735.396% |
| Akari Therapeutics, Plc | 4.35 Million USD | -59899.242% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -15236.714% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -50.754% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -1038.9% |
| Entera Bio Ltd. | 11.76 Million USD | -22109.664% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -231.211% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -3413.28% |
| Xencor, Inc. | 952.69 Million USD | -174.272% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -2644.367% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -2413.773% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -32274.404% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -302.962% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -84626.941% |
| Portage Biotech Inc. | 7.77 Million USD | -33490.012% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -58455.654% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -843.497% |
| OncoCyte Corporation | 74.89 Million USD | -3388.98% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -45055.144% |
| Purple Biotech Ltd. | 44.3 Million USD | -5798.079% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -7556.822% |
| Onconetix, Inc. | 88.82 Million USD | -2841.82% |
| MacroGenics, Inc. | 306.82 Million USD | -751.629% |
| Tharimmune, Inc. | 10.94 Million USD | -23770.575% |
| Genprex, Inc. | 10.67 Million USD | -24387.554% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -550.957% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -426.601% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -4743.492% |
| Prime Medicine, Inc. | 193.85 Million USD | -1247.925% |
| Aditxt, Inc. | 44.57 Million USD | -5761.519% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -107606.801% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -62629.661% |
| OKYO Pharma Limited | 1.54 Million USD | -169434.032% |
| Savara Inc. | 177.56 Million USD | -1371.563% |
| Curis, Inc. | 77.28 Million USD | -3281.081% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -3986.03% |
| Adagene Inc. | 115.72 Million USD | -2157.836% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -13389.066% |
| BeiGene, Ltd. | 5.8 Billion USD | 54.99% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -748.661% |
| GlycoMimetics, Inc. | 45.31 Million USD | -5666.042% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -75.668% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -60338.214% |
| SciSparc Ltd. | 11.18 Million USD | -23267.618% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -60338.214% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -14243.564% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -21295.649% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -4492.16% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -22452.796% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -665.447% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -1789.825% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | 31.774% |
| ADMA Biologics, Inc. | 329.18 Million USD | -693.776% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -2129.019% |
| Clene Inc. | 52.34 Million USD | -4892.199% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -461.172% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -733.65% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -1911.615% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -299.72% |
| Adicet Bio, Inc. | 207.29 Million USD | -1160.507% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -1904.024% |
| Absci Corporation | 234.48 Million USD | -1014.367% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -58563.137% |
| Quantum-Si incorporated | 298.25 Million USD | -776.1% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -33794.478% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -643.84% |
| Surrozen, Inc. | 46.08 Million USD | -5570.501% |
| Generation Bio Co. | 374.75 Million USD | -597.241% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -926.037% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -492.553% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -1547.863% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -586.887% |
| Invivyd, Inc. | 229.18 Million USD | -1040.132% |
| Cingulate Inc. | 3.49 Million USD | -74739.321% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -209.601% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -21371.792% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -22262.434% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -1332.626% |
| Jaguar Health, Inc. | 50.76 Million USD | -5047.385% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -12693.61% |
| 2seventy bio, Inc. | 565.42 Million USD | -362.124% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -7581.131% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -873.11% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -248.881% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -4348.79% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -2421.897% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -2578.536% |
| Kronos Bio, Inc. | 213.27 Million USD | -1125.14% |
| Innoviva, Inc. | 1.24 Billion USD | -110.129% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -1535.312% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -456.908% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -977.277% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | -33.309% |
| Evaxion Biotech A/S | 12.88 Million USD | -20173.444% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -936.645% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -247.151% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -1056.912% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -15613.314% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -3877.724% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -1975.562% |
| Clearmind Medicine Inc. | 4.32 Million USD | -60323.958% |
| AlloVir, Inc. | 190.79 Million USD | -1269.508% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -925.956% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -453.704% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -30423.14% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -609.101% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -606.16% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -40708.48% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -311.262% |
| ImmunityBio, Inc. | 504.45 Million USD | -417.981% |
| Korro Bio, Inc. | 221.66 Million USD | -1078.802% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -594.105% |
| Kineta, Inc. | 10.28 Million USD | -25315.495% |
| Lantern Pharma Inc. | 43.64 Million USD | -5886.506% |
| BioVie Inc. | 25.2 Million USD | -10265.484% |
| Codexis, Inc. | 136.56 Million USD | -1813.406% |
| Celularity Inc. | 143.88 Million USD | -1715.96% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -1975.529% |
| Virax Biolabs Group Limited | 5.48 Million USD | -47547.37% |
| Kodiak Sciences Inc. | 479.37 Million USD | -445.081% |
| Cibus, Inc. | 544.41 Million USD | -379.962% |
| Annexon, Inc. | 297.67 Million USD | -777.795% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -1800.768% |
| Moderna, Inc. | 18.42 Billion USD | 85.819% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | 12.612% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -1410.298% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -12346.849% |
| Immix Biopharma, Inc. | 19.92 Million USD | -13013.907% |
| Eyenovia, Inc. | 28.77 Million USD | -8979.305% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -1033.471% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -760.222% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -850.346% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -36070.64% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -4188.755% |
| Alkermes plc | 2.13 Billion USD | -22.317% |
| Arcellx, Inc. | 825.13 Million USD | -216.673% |
| Moolec Science SA | 24.05 Million USD | -10764.145% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -3100.714% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -2469.036% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -465.241% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -8397.454% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -339.178% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -1565.636% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -37255.77% |
| Humacyte, Inc. | 128.22 Million USD | -1937.83% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -742.553% |
| Geron Corporation | 394.07 Million USD | -563.062% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -3102.283% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -141141.459% |
| Royalty Pharma plc | 16.38 Billion USD | 84.05% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -21625.271% |
| Notable Labs, Ltd. | 19.54 Million USD | -13271.716% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -1055.873% |
| Structure Therapeutics Inc. | 482.01 Million USD | -442.09% |
| IN8bio, Inc. | 33.7 Million USD | -7651.541% |
| 89bio, Inc. | 596.26 Million USD | -338.219% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -4724.533% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -1388.48% |
| Acasti Pharma Inc. | 73.3 Million USD | -3464.757% |
| Genelux Corporation | 27.89 Million USD | -9267.823% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -2822.684% |
| Liquidia Corporation | 120.43 Million USD | -2069.68% |
| Mustang Bio, Inc. | 17.74 Million USD | -14627.579% |
| Immunovant, Inc. | 666.71 Million USD | -291.918% |
| Vericel Corporation | 353.65 Million USD | -638.842% |
| Quantum-Si incorporated | 298.25 Million USD | -776.1% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -1709.521% |
| XOMA Corporation | 234.3 Million USD | -1015.218% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -1020.541% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -57299.071% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -9904.906% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -2333.202% |
| Vaxcyte, Inc. | 1.4 Billion USD | -85.591% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -170.83% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -58563.137% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -11369.94% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -4963.595% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -5669.795% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -685.276% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -1346.097% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -6994.477% |
| PepGen Inc. | 143.05 Million USD | -1726.585% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -6737.185% |
| United Therapeutics Corporation | 7.16 Billion USD | 63.542% |
| Solid Biosciences Inc. | 164.93 Million USD | -1484.202% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -44396.779% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -36070.64% |
| Immuneering Corporation | 102.58 Million USD | -2447.135% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -60545.102% |
| Silo Pharma, Inc. | 7.74 Million USD | -33632.5% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -54635.944% |
| Belite Bio, Inc | 94.64 Million USD | -2660.896% |
| Pharming Group N.V. | 462.85 Million USD | -464.534% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -13707.926% |
| Bionomics Limited | 27.64 Million USD | -9350.462% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -1404.074% |
| uniQure N.V. | 831.68 Million USD | -214.176% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -7963.22% |
| GeoVax Labs, Inc. | 9.28 Million USD | -28047.208% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -854.038% |
| Altimmune, Inc. | 210.64 Million USD | -1140.489% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -64051.58% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -2333.202% |
| Peak Bio, Inc. | 2.59 Million USD | -100537.494% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -74279.932% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -22004.45% |
| Benitec Biopharma Inc. | 52.21 Million USD | -4904.725% |
| Zura Bio Limited | 100.84 Million USD | -2491.124% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -235.909% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -39571.417% |
| Compugen Ltd. | 121.33 Million USD | -2053.532% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -50246.98% |
| argenx SE | 4.54 Billion USD | 42.477% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -1416.284% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -13519.844% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -664.341% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -7414.356% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -307.927% |
| PolyPid Ltd. | 15.37 Million USD | -16898.224% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -2090.506% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -22844.916% |
| Forte Biosciences, Inc. | 38.98 Million USD | -6603.353% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -1356.463% |
| Instil Bio, Inc. | 325.63 Million USD | -702.434% |
| Elevation Oncology, Inc. | 89.09 Million USD | -2832.919% |
| Immunome, Inc. | 148.54 Million USD | -1659.1% |
| Verona Pharma plc | 308.12 Million USD | -748.024% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -42613.127% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -2904.826% |
| Shattuck Labs, Inc. | 159.56 Million USD | -1537.567% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -1286.513% |
| Design Therapeutics, Inc. | 289.64 Million USD | -802.134% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -3488.008% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -48127.519% |
| Achilles Therapeutics plc | 161.45 Million USD | -1518.377% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -3328.551% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -4411.65% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -396.252% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -79.005% |
| Moolec Science SA | 24.05 Million USD | -10764.145% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -5054.086% |
| AEON Biopharma, Inc. | 6.84 Million USD | -38073.367% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -1873.197% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -861.12% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -234.845% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -878.661% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -1410.871% |
| Athira Pharma, Inc. | 160.24 Million USD | -1530.608% |
| HCW Biologics Inc. | 28.51 Million USD | -9063.913% |
| XOMA Corporation | 234.3 Million USD | -1015.218% |
| NeurAxis, Inc. | 509.49 Thousand USD | -512751.277% |
| Lumos Pharma, Inc. | 40.63 Million USD | -6329.861% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -2904.826% |
| 180 Life Sciences Corp. | 5.25 Million USD | -49581.128% |
| Nektar Therapeutics | 398.03 Million USD | -556.47% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -7414.356% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -3610.136% |
| Arvinas, Inc. | 1.3 Billion USD | -100.289% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -30423.14% |
| Palisade Bio, Inc. | 14.05 Million USD | -18494.983% |
| Nutriband Inc. | 7.51 Million USD | -34660.057% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -15236.714% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -1211.066% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -1142.525% |
| Merus N.V. | 458.49 Million USD | -469.902% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -1178.572% |
| Neurogene Inc. | 222.57 Million USD | -1073.982% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -304.096% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -42031.038% |
| CervoMed Inc. | 9.97 Million USD | -26101.67% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -476.768% |
| Sesen Bio, Inc. | 189.17 Million USD | -1281.251% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -1350.005% |
| Rezolute, Inc. | 132.73 Million USD | -1868.529% |
| Clene Inc. | 52.34 Million USD | -4892.199% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -17408.633% |
| BeyondSpring Inc. | 24.8 Million USD | -10432.76% |
| Synlogic, Inc. | 75.55 Million USD | -3358.593% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -21928.048% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -27804.389% |
| Peak Bio, Inc. | 2.59 Million USD | -100537.494% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -1394.55% |
| Krystal Biotech, Inc. | 818.35 Million USD | -219.295% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -986.753% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -260.018% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -72945.566% |
| MannKind Corporation | 475.19 Million USD | -449.869% |
| Ikena Oncology, Inc. | 192.09 Million USD | -1260.269% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -19437.663% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -2142.14% |
| Gossamer Bio, Inc. | 311.91 Million USD | -737.715% |
| CohBar, Inc. | 16.36 Million USD | -15866.15% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -7331.013% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -35620.67% |
| Legend Biotech Corporation | 1.84 Billion USD | -41.348% |
| Mural Oncology plc | 301.74 Million USD | -765.952% |
| Disc Medicine, Inc. | 367.99 Million USD | -610.053% |
| Champions Oncology, Inc. | 26.13 Million USD | -9899.108% |
| REGENXBIO Inc. | 573.97 Million USD | -355.245% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -96387.629% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -1592.49% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -21538.439% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -668.441% |
| Vaxart, Inc. | 91.83 Million USD | -2745.439% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -4261.933% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -1661.627% |
| Cellectis S.A. | 334.27 Million USD | -681.694% |
| Longeveron Inc. | 12.17 Million USD | -21356.454% |
| Repare Therapeutics Inc. | 253.9 Million USD | -929.128% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | 19.96% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -1200.974% |
| Revolution Medicines, Inc. | 2.08 Billion USD | -25.107% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -160697.969% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -840.894% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -1502.084% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -1783.301% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -10138.097% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 88.504% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -126.443% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -21295.649% |
| Veru Inc. | 50.59 Million USD | -5064.382% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -5636.103% |
| Cingulate Inc. | 3.49 Million USD | -74739.321% |
| Passage Bio, Inc. | 150.54 Million USD | -1635.672% |
| Context Therapeutics Inc. | 16.06 Million USD | -16167.261% |
| Exicure, Inc. | 11.58 Million USD | -22464.482% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -594.849% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -1516.515% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -14855.168% |
| Nuvalent, Inc. | 732.38 Million USD | -256.776% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -17384.965% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -2817.756% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -18312.846% |
| OmniAb, Inc. | 401.98 Million USD | -550.016% |
| Anew Medical, Inc. | 19.45 Million USD | -13330.167% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -9676.67% |
| Lipocine Inc. | 23 Million USD | -11260.197% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -1768.982% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -755.126% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -3012.852% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -2049.882% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -32829.641% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -196.162% |
| Ocugen, Inc. | 64.54 Million USD | -3948.162% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -1998.078% |
| Q32 Bio Inc. | 306.11 Million USD | -753.579% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -61995.223% |
| Alumis Inc. Common Stock | 89.61 Million USD | -2815.867% |
| Equillium, Inc. | 50.53 Million USD | -5071.12% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -3374.921% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -6230.855% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -153526.857% |
| Dominari Holdings Inc. | 57.55 Million USD | -4439.711% |
| Edesa Biotech, Inc. | 8.89 Million USD | -29290.76% |
| vTv Therapeutics Inc. | 11.01 Million USD | -23615.438% |
| Bio-Techne Corporation | 2.81 Billion USD | 7.117% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -178.83% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -222.013% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -841.05% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -6165.807% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -291.404% |
| Nkarta, Inc. | 378.88 Million USD | -589.646% |
| BioCardia, Inc. | 2.98 Million USD | -87377.971% |
| Iterum Therapeutics plc | 26.25 Million USD | -9850.748% |